Goal and Learning Outcomes

Upon completion of this activity, participants should be better able to:

  • Review risk factors for DR, DME, and neovascular AMD, as well as their etiology and typical progression
  • Describe the guideline-recommended screening strategies for DR, DME, and neovascular AMD, and the optimal use of imaging technologies in screening and diagnosis
  • Evaluate the appropriate patients, risks, benefits, and guideline recommendations for DR, DME, and neovascular AMD therapies
  • Identify opportunities for eyecare providers to provide team-based care for DR, DME, and neovascular AMD alongside primary care providers and other specialists


Quan Dong Nguyen, MD, MSc, FARVO

Professor of Ophthalmology
Byers Eye Institute
Stanford University School of Medicine
Palo Alto, CA

A. Paul Chous, MA, OD, FAAO

Medical Director, Chous Eye Care Associates,
Tacoma, WA
Adjunct Professor, Western University of Health Sciences
Pomona, CA

Accreditation Information

This course is being provided by a Relias LLC strategic partner.  Consumption of this course will take place on the partners site and courses provided in this manner are not accredited by Relias LLC.